BIOMAT Database Logo BIOMAT Database Logo

In vitro production of islet cell antibodies from peripheral blood lymphocytes in insulin-dependent diabetics. 1987

Y Yamaguchi, and A Yokota, and T Nakanishi, and Y Ueda, and A Takahashi, and N Kuriya, and T Mori, and K Toyama, and S Akazawa, and S Miyake

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011043 Pokeweed Mitogens Proteins isolated from the roots of the pokeweed, Phytolacca americana, that agglutinate some erythrocytes, stimulate mitosis and antibody synthesis in lymphocytes, and induce activation of plasma cells. Lectins, Pokeweed,Pokeweed Lectin,Pokeweed Lectins,Pokeweed Mitogen,Pokeweed Mitogen Isolectin,Isolectin, Pokeweed Mitogen,Lectin, Pokeweed,Mitogen Isolectin, Pokeweed,Mitogen, Pokeweed,Mitogens, Pokeweed
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Y Yamaguchi, and A Yokota, and T Nakanishi, and Y Ueda, and A Takahashi, and N Kuriya, and T Mori, and K Toyama, and S Akazawa, and S Miyake
Production of islet cell antibodies from Epstein-Barr virus-transformed peripheral blood lymphocytes in type 1 (insulin-dependent) diabetic patients.
July 1991, Diabetologia,
Y Yamaguchi, and A Yokota, and T Nakanishi, and Y Ueda, and A Takahashi, and N Kuriya, and T Mori, and K Toyama, and S Akazawa, and S Miyake
[Anti-islet cell antibodies in insulin-dependent diabetics. Preliminary study].
October 1978, Minerva medica,
Y Yamaguchi, and A Yokota, and T Nakanishi, and Y Ueda, and A Takahashi, and N Kuriya, and T Mori, and K Toyama, and S Akazawa, and S Miyake
Islet-cell antibodies and beta-cell function in insulin-dependent diabetics.
January 1980, Diabetologia,
Y Yamaguchi, and A Yokota, and T Nakanishi, and Y Ueda, and A Takahashi, and N Kuriya, and T Mori, and K Toyama, and S Akazawa, and S Miyake
Islet-cell antibodies and HLA type in Japanese insulin-dependent diabetics.
April 1980, Endocrinologia japonica,
Y Yamaguchi, and A Yokota, and T Nakanishi, and Y Ueda, and A Takahashi, and N Kuriya, and T Mori, and K Toyama, and S Akazawa, and S Miyake
Islet cell surface antibodies from insulin-dependent diabetics bind specifically to pancreatic B cells.
July 1982, The Journal of clinical investigation,
Y Yamaguchi, and A Yokota, and T Nakanishi, and Y Ueda, and A Takahashi, and N Kuriya, and T Mori, and K Toyama, and S Akazawa, and S Miyake
Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics.
March 1985, Lancet (London, England),
Y Yamaguchi, and A Yokota, and T Nakanishi, and Y Ueda, and A Takahashi, and N Kuriya, and T Mori, and K Toyama, and S Akazawa, and S Miyake
[Subpopulations of peripheral lymphocytes in insulin-dependent diabetics (author's transl)].
January 1978, Nihon Naibunpi Gakkai zasshi,
Y Yamaguchi, and A Yokota, and T Nakanishi, and Y Ueda, and A Takahashi, and N Kuriya, and T Mori, and K Toyama, and S Akazawa, and S Miyake
Lymphocytes from diabetics suppress insulin release in vitro.
July 1981, Diabetologia,
Y Yamaguchi, and A Yokota, and T Nakanishi, and Y Ueda, and A Takahashi, and N Kuriya, and T Mori, and K Toyama, and S Akazawa, and S Miyake
Islet-cell antibodies in Spanish diabetics.
July 1978, Lancet (London, England),
Y Yamaguchi, and A Yokota, and T Nakanishi, and Y Ueda, and A Takahashi, and N Kuriya, and T Mori, and K Toyama, and S Akazawa, and S Miyake
Islet cell antibodies in Nigerian diabetics.
May 1980, Lancet (London, England),
Copied contents to your clipboard!